NextCure, Inc. (NXTC)
NASDAQ · Healthcare
NextCure, Inc. Operating Income 2020–2025
NextCure, Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- NextCure, Inc. operating income for the quarter ending March 31, 2026 was -10.1 M, a 13.05% decrease year-over-year.
- NextCure, Inc. operating income for the twelve months ending March 31, 2026 was -56.1 M.
- NextCure, Inc. annual operating income for 2025 was -57.6 M, a 0.72% increase from 2024.
- NextCure, Inc. annual operating income for 2024 was -57.2 M, a 15.42% decrease from 2023.
- NextCure, Inc. annual operating income for 2023 was -67.6 M, a 10.90% decrease from 2022.
- NextCure, Inc. annual operating income for 2022 was -75.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
NextCure, Inc. Operating Income — FAQ
NextCure, Inc. (NXTC) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is NextCure, Inc.'s operating income?
NextCure, Inc. (NXTC) reported operating income of -$58M for fiscal 2025.
Where can I see NXTC's operating income history?
The chart and table above show NextCure, Inc.'s operating income by year and by quarter, including the growth rate.